---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-058528"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:17:49.283492+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Organovo shareholders approve 2023 ESPP but reject officer exculpation amendment

## Summary
- 2023 ESPP approved with 91.11% of votes cast; reserves 45,000 shares; effective October 31, 2023.
- Amendment to certificate of incorporation (officer exculpation) failed: 794,723 for, 63,936 against; needed majority of 8,718,203 outstanding shares.
- Directors Keith Murphy (786,897 for) and Adam Stern (812,172 for) elected as Class III directors until 2026.
- Ratification of auditor Rosenberg Rich Baker Berman P.A. approved by 91.83% of votes cast.
- Advisory vote on named-executive compensation approved by 85.78% of votes cast.

## SEC filing metadata
- accession: 0000950170-23-058528
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/onvo-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-058528
- JSON: https://secwatch.observer/filing/0000950170-23-058528.json
- Plain text: https://secwatch.observer/filing/0000950170-23-058528.txt

## Key facts
- Shareholder Votes
  VivoSim Labs, INC. shareholders rejected Amendment to Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation at the 2023-10-31 meeting.
  - Proposal: charter amendment
  - Outcome: failed
  - Meeting: 2023-10-31
  source text: The Company held the Annual Meeting on October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
- Shareholder Votes
  VivoSim Labs, INC. shareholders approved Election of Keith Murphy and Adam Stern as Class III directors at the 2023-10-31 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-10-31
  source text: The Company held the Annual Meeting on October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
- Shareholder Votes
  VivoSim Labs, INC. shareholders approved Advisory vote on compensation of named executive officers at the 2023-10-31 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-10-31
  source text: The Company held the Annual Meeting on October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
- Shareholder Votes
  VivoSim Labs, INC. shareholders approved Approval of 2023 ESPP at the 2023-10-31 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-10-31
  source text: The Company held the Annual Meeting on October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm
- Shareholder Votes
  VivoSim Labs, INC. shareholders approved Ratification of appointment of Rosenberg Rich Baker Berman P.A. as independent registered public accounting firm for fiscal year ending March 31, 2024 at the 2023-10-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-10-31
  source text: The Company held the Annual Meeting on October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497253/000095017023058528/0000950170-23-058528-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.